231 related articles for article (PubMed ID: 3653773)
41. Second-look laparotomy in epithelial ovarian carcinoma: precise definition, sensitivity, and specificity of the operative procedure.
Ballon SC; Portnuff JC; Sikic BI; Turbow MM; Teng NN; Soriero OM
Gynecol Oncol; 1984 Feb; 17(2):154-60. PubMed ID: 6706223
[TBL] [Abstract][Full Text] [Related]
42. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma.
Eifel PJ; Gershenson DM; Delclos L; Wharton JT; Peters LJ
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1013-8. PubMed ID: 1917596
[TBL] [Abstract][Full Text] [Related]
43. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
[TBL] [Abstract][Full Text] [Related]
44. Polychemotherapy and second-look laparotomy in the management of the ovarian cancer.
Draca P
Eur J Gynaecol Oncol; 1988; 9(5):410-4. PubMed ID: 3224611
[TBL] [Abstract][Full Text] [Related]
45. Feasibility and outcome of complete secondary tumor resection for patients with advanced ovarian cancer.
Lawton F; Luesley D; Redman C; Chan KK; Varma R; Blackledge G
J Surg Oncol; 1990 Sep; 45(1):14-9. PubMed ID: 2381211
[TBL] [Abstract][Full Text] [Related]
46. Abdominopelvic irradiation for stage II-IV ovarian carcinoma patients with limited or no residual disease at second-look laparotomy after completion of cisplatinum-based combination chemotherapy.
Menczer J; Modan M; Brenner J; Ben-Baruch G; Brenner H
Gynecol Oncol; 1986 Jun; 24(2):149-54. PubMed ID: 3710262
[TBL] [Abstract][Full Text] [Related]
47. [Follow-up of 70 patients with advanced ovarian cancer after negative second-look laparotomy].
Kojs Z; Glinski B; Pudelek J; Urbanski K; Karolewski K; Mitus J; Reinfuss M
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1):16-22. PubMed ID: 16446607
[TBL] [Abstract][Full Text] [Related]
48. The prognostic and therapeutic value of second-look laparotomy in advanced ovarian cancer.
Bertelsen K; Hansen MK; Pedersen PH; Larsen G; Nyland M; Jacobsen M; Andersen JE
Br J Obstet Gynaecol; 1988 Dec; 95(12):1231-6. PubMed ID: 3224088
[TBL] [Abstract][Full Text] [Related]
49. Second-look operations in ovarian cancer.
Schwartz PE; Smith JP
Am J Obstet Gynecol; 1980 Dec; 138(8):1124-30. PubMed ID: 7446620
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
Rubin SC; Hoskins WJ; Saigo PE; Chapman D; Hakes TB; Markman M; Reichman B; Almadrones L; Lewis JL
Gynecol Oncol; 1991 Aug; 42(2):137-41. PubMed ID: 1894172
[TBL] [Abstract][Full Text] [Related]
51. Second-look laparotomy in managing epithelial ovarian carcinoma.
Dauplat J; Ferriere JP; Gorbinet M; Legros M; Chollet P; Giraud B; Plagne R
Cancer; 1986 Apr; 57(8):1627-31. PubMed ID: 3948133
[TBL] [Abstract][Full Text] [Related]
52. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
53. The treatment of advanced ovarian carcinoma (II): interval reassessment operations during chemotherapy.
Heintz AP; Van Oosterom AT; Trimbos JB; Schaberg A; Van der Velde E; Nooy M
Gynecol Oncol; 1988 Jul; 30(3):359-71. PubMed ID: 2968942
[No Abstract] [Full Text] [Related]
54. The value of second-look operation in patients with advanced epithelial ovarian carcinoma.
Sevelda P; Dittrich C; Salzer H
Arch Gynecol Obstet; 1989; 244(2):79-86. PubMed ID: 2712601
[TBL] [Abstract][Full Text] [Related]
55. The significance of müllerian inclusions found at second-look laparotomy in patients with epithelial ovarian neoplasms.
Copeland LJ; Silva EG; Gershenson DM; Sneige N; Atkinson EN; Wharton JT
Obstet Gynecol; 1988 May; 71(5):763-70. PubMed ID: 2833713
[TBL] [Abstract][Full Text] [Related]
56. Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients.
Bozkurt N; Yuce K; Basaran M; Gariboglu S; Kose F; Ayhan A
Int J Gynecol Cancer; 2006; 16(1):83-6. PubMed ID: 16445615
[TBL] [Abstract][Full Text] [Related]
57. Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
Chiara S; Conte PF; Bruzzone M; Falcone A; Sertoli MR; Carnino F; Mossetti C; Iura R; Durando C; Guercio E
Chemioterapia; 1987 Oct; 6(5):380-3. PubMed ID: 3427698
[TBL] [Abstract][Full Text] [Related]
58. ACOG Committee opinion. Second-look laparotomy for epithelial ovarian cancer. Number 165, December 1995 (replaces no. 100, November 1991). Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists.
Int J Gynaecol Obstet; 1996 Apr; 53(1):81-3. PubMed ID: 8737312
[TBL] [Abstract][Full Text] [Related]
59. Current management of epithelial ovarian carcinoma: a review.
Marsden DE; Friedlander M; Hacker NF
Semin Surg Oncol; 2000; 19(1):11-9. PubMed ID: 10883019
[TBL] [Abstract][Full Text] [Related]
60. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second-look laparotomy.
Menczer J; Ben-Baruch G; Modan M; Brenner H
Cancer; 1989 Apr; 63(8):1509-13. PubMed ID: 2924259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
